Onset of protection from experimental infection with type 2 bovine viral diarrhea virus following vaccination with a modified-live vaccine

Veterinary Therapeutics

Volumn 8, Issue 1, 2007, Pages 88-96

  Brock, K V ^a   Widel, P ^b   Walz, P ^a   Walz, H L ^a  

^a AUBURN UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOS; BOVINE VIRAL DIARRHEA VIRUS 1;

LIVE VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ARTICLE; BLOOD; BOVINE DIARRHEA VIRUS; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; IMMUNOLOGY; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CATTLE DISEASES; DIARRHEA VIRUS 2, BOVINE VIRAL; INJECTIONS, SUBCUTANEOUS; MALE; VACCINES, ATTENUATED; VIRAL VACCINES; VIRUS SHEDDING;

EID: 34249744451     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Peterhans E, Jungi TW, Schweizer M: BVD virus and innate immunity. Biologicals 31:107-112, 2003.
2. Jones L, Van Campen H, Zu ZC, Schnackel JA: Comparison of neutralizing antibodies to type 1a, 1b and 2 bovine viral diarrhea virus from experimentally infected and vaccinated cattle. Bovine Pract 35:137-140, 2001.
3. Fulton RW, Ridpath JF, Saliki JT, et al: Bovine viral diarrhea virus (BVDV) 1b: Predominant BVDV subtype in calves with respiratory disease. Can J Vet Res 66:18, 2002.
4. Hamers C, di Valentin E, Lecomte C, et al: Virus neutralizing antibodies against a 22 bovine isolates in vaccinated calves. Vet J 163:61-67, 2002.
5. Cortese VS, Whittaker R, Ellis J, et al: Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea. Am J Vet Res 59: 848-850, 1998.
6. Lambot M, Douart A, Joris E, et al: Characterization of the immune response of cattle against non-cytopathic and cytopathic biotypes of bovine viral diarrhoea virus. J Gen Virol 78:1041-1047, 1997.
7. Endsley JJ, Quade MJ, Terhaar B, Roth JA: Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination. Vet Ther 3:364-372, 2002.
8. Fairbanks KF, Campbell J, Chase CCL: Rapid onset of protection against infectious bovine rhinotracheitis with a modified-live virus multivalent vaccine. Vet Ther 5(1):17-25, 2004.
9. Brock KV: The many faces of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 20(1):1-3, 2004.
10. Brock KV: Strategies for the control and prevention of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 20(1):171-180, 2004.
11. Brock KV, Grooms D: Reproductive consequences of bovine viral diarrhea virus infections, in Goyal SM, Ridpath JF (eds): Bovine Viral Diarrhea Virus: Diagnosis, Management and Control, Ames, IA, Blackwell Publishing, 2005.
12. Liebler-Tenoria E, Ridpath JE, Neill JD: Distribution of viral antigen and development of lesions after experimental infection with highly virulent bovine viral diarrhea virus in calves. Am J Vet Res 63(10:1575-1584, 2002.
13. Stoffregen B, Bolin SR, Ridpath JF, Pohtenz J: Morphologic lesions in type 2 BVDV infections experimentally induced by strain BVDV2-1373 recovered from a field case. Vet Microbiol 77:157-162, 2000.
14. Ridpath JF, Neill JD, Vilcek S, et al: Multiple outbreaks of severe acute BVDV in North America occurring between 1993 and 1995 linked to the same BVDV2 strain. Vet Micro 114:196-204, 2006.
15. Corapi WV, Elliott RD, French TW, et al: Thrombocytopenia in young calves experimentally infected with noncytopathic bovine viral diarrhea virus. JAVMA 196(4):590-5595, 1990.
16. Ridpath JF, Bendfeldt S, Neill JD, Liebler-Tenorio E: Lymphocytopath ogenic activity in vitro correlates with high virulence in vivo for BVDV type 2 strains: Criteria for a third biotype of BVDV. [i Virus Res 118: 62-69, 2006.